Valeris™ Expands Strategic Infrastructure with Launch of Transformation Office
Designed to guide integration activities without disruption, the Transformation Office reinforces Valeris's focus on execution and delivery of sustained value...
Day: June 17, 2025
Altera Digital Health Makes Sunrise 25.1 Generally Available to Hospitals and Health Systems
Nearly 700 new features and enhancements to drive financial and clinical improvementsNIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Altera Digital Health, a global health...
HeartBeam to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24, 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized...
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the...
Orthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport System
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the global commercial launch of the...
Canadian Dental Hygienists Association (CDHA) Responds to Misinformation, Say Challenging Work Environments Must Be Addressed
Ottawa, Ontario--(Newsfile Corp. - June 17, 2025) - Thousands of dental hygienists across Canada are delivering essential care through the...
Canadian Dental Hygienists Association (CDHA) Responds to Misinformation, Say Challenging Work Environments Must Be Addressed
Ottawa, Ontario--(Newsfile Corp. - June 17, 2025) - Thousands of dental hygienists across Canada are delivering essential care through the...
Hemostemix Closes Private Placement of $469,366
Calgary, Alberta--(Newsfile Corp. - June 17, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company")...
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward CommercializationCHASKA, Minn., June 17, 2025 (GLOBE...
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
Late-breaking poster presentation to be reviewed at the upcoming American Diabetes Association’s 85th Scientific SessionsBOSTON and SHANGHAI, June 17, 2025...
Counslr Partners with Hacking HR to Provide 24/7 Mental Health Support for Members
Supporting Professionals Who Are Shaping the Future of WorkNEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Hacking HR, the fastest...
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical...
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3...
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF...
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on...
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to...
Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced...
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology careiMDx sponsoring GraftAssureIQ™ research-use-only kits...
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure,...
ProMIS Neurosciences Presents at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
Webcast of virtual fireside chat today, June 17th, at 7:00 a.m. ETCAMBRIDGE, Massachusetts, June 17, 2025 (GLOBE NEWSWIRE) -- ProMIS...